{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:14:05Z","timestamp":1773893645769,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yunnan health training project of high level talents","award":["H-2019027"],"award-info":[{"award-number":["H-2019027"]}]},{"name":"scientific research institutions set up in the Yunnan Provincial Department of Health","award":["2016NS143"],"award-info":[{"award-number":["2016NS143"]}]},{"name":"scientific research institutions set up in the Yunnan Provincial Department of Health","award":["2016NS143"],"award-info":[{"award-number":["2016NS143"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diagnosis of pulmonary tuberculosis (PTB) among people living with HIV (PLHIV) was challenging. The study aimed to develop and validated a simple, convenient screening model for prioritizing TB among PLHIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included eligible adult PLHIV participants who attended health care in Yunnan, China, from January 2016 to July 2019. Participants included before June 2018 were in the primary set; others were in the independent validation set. The research applied the least absolute shrinkage and selection operator regression to identify predictors associated with bacteriological confirmed PTB. The TB nomogram was developed by multivariate logistic regression. The C-index, receiver operating characteristic curve (ROC), the Hosmer\u2013Lemeshow goodness of fit test (H\u2013L), and the calibration curves were applied to evaluate and calibrate the nomogram. The developed nomogram was validated in the validation set. The clinical usefulness was assessed by cutoff analysis and decision curve analysis in the primary set.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>The study enrolled 766 PLHIV, of which 507 were in the primary set and 259 in the validation set, 21.5% and 14.3% individuals were confirmed PTB in two sets, respectively. The final nomogram included 5 predictors: current CD 4 cell count, the number of WHO screen tool, previous TB history, pulmonary cavity, and smoking status (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The C-statistic was 0.72 (95% CI 0.66\u20130.77) in primary set and 0.68 (95% CI 0.58\u20130.75) in validation set, ROC performed better than other models. The nomogram calibration was good (H\u2013L <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20098.14, <jats:italic>p<\/jats:italic>\u2009=\u20090.15). The area under the decision curve (0.025) outperformed the existing models. The optimal cutoff for screening TB among PLHIV was the score of 100 (sensitivity\u2009=\u20090.93, specificity\u2009=\u20090.35).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study developed and validated a discriminative TB nomogram among PLHIV in the moderate prevalence of TB and HIV. The easy-to-use and straightforward nomogram would be beneficial for clinical practice and rapid risk screening in resource-limited settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07368-5","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T14:03:24Z","timestamp":1650377004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting the risk of active pulmonary tuberculosis in people living with HIV: development and validation of a nomogram"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinou","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohao","family":"Ru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"7368_CR1","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"JD Stanaway","year":"2018","unstructured":"Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Stu. Lancet. 2018;392:1923\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(18)32225-6.","journal-title":"Lancet"},{"key":"7368_CR2","unstructured":"World Health Organization. Global tuberculosis report 2020. Geneva; 2020."},{"key":"7368_CR3","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1016\/S2352-3018(15)00252-0","volume":"3","author":"DN Podlekareva","year":"2016","unstructured":"Podlekareva DN, Efsen AMW, Schultze A, Post FA, Skrahina AM, Panteleev A, et al. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Lancet HIV. 2016;3:e120\u201331. https:\/\/doi.org\/10.1016\/S2352-3018(15)00252-0.","journal-title":"Lancet HIV"},{"key":"7368_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12879-018-3656-x","volume":"19","author":"M Lisboa","year":"2019","unstructured":"Lisboa M, Fronteira I, Colove E, Nhamonga M, Martins MdRO. Time delay and associated mortality from negative smear to positive Xpert MTB\/RIF test among TB\/HIV patients: a retrospective study. BMC Infect Dis. 2019;19:18. https:\/\/doi.org\/10.1186\/s12879-018-3656-x.","journal-title":"BMC Infect Dis"},{"key":"7368_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9: e1001270. https:\/\/doi.org\/10.1371\/journal.pmed.1001270.","journal-title":"PLoS Med"},{"key":"7368_CR6","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","volume":"369","author":"H Getahun","year":"2007","unstructured":"Getahun H, Harrington M, O\u2019Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. The Lancet. 2007;369:2042\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(07)60284-0.","journal-title":"The Lancet"},{"key":"7368_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8: e1000391. https:\/\/doi.org\/10.1371\/journal.pmed.1000391.","journal-title":"PLoS Med"},{"key":"7368_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2471\/BLT.08.055467","volume":"88","author":"E Corbett","year":"2010","unstructured":"Corbett E, Zezai A, Cheung YB, Bandason T, Dauya E, Munyati S, et al. Provider-initiated sympton screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010;88:13\u201321. https:\/\/doi.org\/10.2471\/BLT.08.055467.","journal-title":"Bull World Health Organ"},{"key":"7368_CR9","volume-title":"WHO operational handbook on tuberculosis Module 2: screening","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO operational handbook on tuberculosis Module 2: screening. Geneva: World Health Organization; 2021."},{"key":"7368_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00387-X","author":"A Dhana","year":"2021","unstructured":"Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(21)00387-X.","journal-title":"Lancet Infect Dis"},{"key":"7368_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","volume":"363","author":"CC Boehme","year":"2010","unstructured":"Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005\u201315. https:\/\/doi.org\/10.1056\/NEJMoa0907847.","journal-title":"N Engl J Med"},{"key":"7368_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009593.pub3","author":"KR Steingart","year":"2014","unstructured":"Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD009593.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"7368_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, et al. Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18:76\u201384. https:\/\/doi.org\/10.1016\/S1473-3099(17)30691-6.","journal-title":"Lancet Infect Dis"},{"key":"7368_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009593.pub4","author":"DJ Horne","year":"2019","unstructured":"Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, et al. Xpert MTB\/RIF and Xpert MTB\/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD009593.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"7368_CR15","volume-title":"WHO consolidated guidelines on tuberculosis Module 2: Screening","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis Module 2: Screening. Geneva: World Health Organization; 2021."},{"key":"7368_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofu095","volume":"1","author":"TT Balcha","year":"2014","unstructured":"Balcha TT, Skogmar S, Stureg\u00e5rd E, Sch\u00f6n T, Winqvist N, Reepalu A, et al. A clinical scoring algorithm for determination of the risk of tuberculosis in HIV-infected adults: a cohort study performed at Ethiopian health centers. Open Forum Infect Dis. 2014;1:1\u20139. https:\/\/doi.org\/10.1093\/ofid\/ofu095.","journal-title":"Open Forum Infect Dis"},{"key":"7368_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181519","volume":"12","author":"Y Hanifa","year":"2017","unstructured":"Hanifa Y, Fielding KL, Chihota VN, Adonis L, Charalambous S, Foster N, et al. A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa. PLoS ONE. 2017;12: e0181519. https:\/\/doi.org\/10.1371\/journal.pone.0181519.","journal-title":"PLoS ONE"},{"key":"7368_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofz543","volume":"7","author":"TH Boyles","year":"2020","unstructured":"Boyles TH, Nduna M, Pitsi T, Scott L, Fox MP, Maartens G. A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV. Open Forum Infect Dis. 2020;7:1\u20139. https:\/\/doi.org\/10.1093\/ofid\/ofz543.","journal-title":"Open Forum Infect Dis"},{"key":"7368_CR19","unstructured":"Health Commission of Yunnan Province. Overview of notifiable infectious diseases of Yunnan Province in 2020. Kunming; 2020."},{"key":"7368_CR20","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594\u2013g7594. https:\/\/doi.org\/10.1136\/bmj.g7594.","journal-title":"BMJ"},{"key":"7368_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1874285801812010163","volume":"12","author":"M Mama","year":"2018","unstructured":"Mama M, Manilal A, Tesfa H, Mohammed H, Erbo E. Prevalence of pulmonary tuberculosis and associated factors among HIV positive patients attending antiretroviral therapy clinic at Arba Minch General Hospital Southern Ethiopia. Open Microbiol J. 2018;12:163\u201371. https:\/\/doi.org\/10.2174\/1874285801812010163.","journal-title":"Open Microbiol J"},{"key":"7368_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","volume":"29","author":"E Liu","year":"2015","unstructured":"Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS. 2015;29:1391\u20139. https:\/\/doi.org\/10.1097\/QAD.0000000000000705.","journal-title":"AIDS"},{"key":"7368_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2334-14-148","volume":"14","author":"B Karo","year":"2014","unstructured":"Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L. Tuberculosis among people living with HIV\/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis. 2014;14:148. https:\/\/doi.org\/10.1186\/1471-2334-14-148.","journal-title":"BMC Infect Dis"},{"key":"7368_CR24","doi-asserted-by":"publisher","first-page":"2633851","DOI":"10.1093\/ofid\/ofv154","volume":"2","author":"CA Chang","year":"2015","unstructured":"Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, et al. Tuberculosis incidence and risk factors among human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy in a large HIV program in Nigeria. Open Forum Infect Dis. 2015;2:2633851. https:\/\/doi.org\/10.1093\/ofid\/ofv154.","journal-title":"Open Forum Infect Dis"},{"key":"7368_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3904\/kjim.2014.322","volume":"31","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Woo JH, Kim MJ, Park DW, Song JY, Kim SW, et al. Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV\/AIDS cohort study, 2006 to 2013. Korean J Intern Med. 2016;31:953\u201360. https:\/\/doi.org\/10.3904\/kjim.2014.322.","journal-title":"Korean J Intern Med"},{"key":"7368_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1089\/aid.2012.0239","volume":"29","author":"ZC M\u00e9da","year":"2013","unstructured":"M\u00e9da ZC, Sombi\u00e9 I, Sanon OWC, Mar\u00e9 D, Morisky DE, Chen Y-MA. Risk factors of tuberculosis infection among HIV\/AIDS patients in Burkina Faso. AIDS Res Human Retrovir. 2013;29:1045\u201355. https:\/\/doi.org\/10.1089\/aid.2012.0239.","journal-title":"AIDS Res Human Retrovir."},{"key":"7368_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/sim.8806","volume":"40","author":"RD Riley","year":"2021","unstructured":"Riley RD, Van Calster B, Collins GS. A note on estimating the Cox-Snell R2 from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a binary outcome. Stat Med. 2021;40:859\u201364. https:\/\/doi.org\/10.1002\/sim.8806.","journal-title":"Stat Med"},{"key":"7368_CR28","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441. https:\/\/doi.org\/10.1136\/bmj.m441.","journal-title":"BMJ"},{"key":"7368_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010736","volume":"5","author":"L Gao","year":"2010","unstructured":"Gao L, Zhou F, Li X, Jin Q. HIV\/TB co-infection in mainland china: a meta-analysis. PLoS ONE. 2010;5: e10736. https:\/\/doi.org\/10.1371\/journal.pone.0010736.","journal-title":"PLoS ONE"},{"key":"7368_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","volume":"73","author":"R Tibshirani","year":"2011","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J Roy Stat Soc B. 2011;73:273\u201382. https:\/\/doi.org\/10.1111\/j.1467-9868.2011.00771.x.","journal-title":"J Roy Stat Soc B"},{"key":"7368_CR31","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512\u201328. https:\/\/doi.org\/10.1002\/sim.3148.","journal-title":"Stat Med"},{"key":"7368_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230. https:\/\/doi.org\/10.1186\/s12916-019-1466-7.","journal-title":"BMC Med"},{"key":"7368_CR33","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and calibration of clinical prediction models. JAMA. 2017;318:1377. https:\/\/doi.org\/10.1001\/jama.2017.12126.","journal-title":"JAMA"},{"key":"7368_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jclinepi.2019.09.016","volume":"118","author":"RJ Stevens","year":"2020","unstructured":"Stevens RJ, Poppe KK. Validation of clinical prediction models: what does the \u201ccalibration slope\u201d really measure? J Clin Epidemiol. 2020;118:93\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.09.016.","journal-title":"J Clin Epidemiol"},{"key":"7368_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res. 2019;3:18. https:\/\/doi.org\/10.1186\/s41512-019-0064-7.","journal-title":"Diagn Progn Res"},{"key":"7368_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74:796\u2013804. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.038.","journal-title":"Eur Urol"},{"key":"7368_CR37","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S2352-3018(18)30137-1","volume":"5","author":"Y Hamada","year":"2018","unstructured":"Hamada Y, Lujan J, Schenkel K, Ford N, Getahun H. Sensitivity and specificity of WHO\u2019s recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. The Lancet HIV. 2018;5:e515\u201323. https:\/\/doi.org\/10.1016\/S2352-3018(18)30137-1.","journal-title":"The Lancet HIV"},{"key":"7368_CR38","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1910708","volume":"382","author":"F-X Blanc","year":"2020","unstructured":"Blanc F-X, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, et al. Systematic or test-guided treatment for tuberculosis in HIV-infected adults. N Engl J Med. 2020;382:2397\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1910708.","journal-title":"N Engl J Med"},{"key":"7368_CR39","doi-asserted-by":"publisher","first-page":"ofu095","DOI":"10.1093\/ofid\/ofu095","volume":"1","author":"TT Balcha","year":"2014","unstructured":"Balcha TT, Skogmar S, Stureg\u00e5rd E, Sch\u00f6n T, Winqvist N, Reepalu A, et al. A clinical scoring algorithm for determination of the risk of tuberculosis in HIV-infected adults: a cohort study performed at Ethiopian health centers. Open Forum Infect Dis. 2014;1:ofu095. https:\/\/doi.org\/10.1093\/ofid\/ofu095.","journal-title":"Open Forum Infect Dis"},{"key":"7368_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ije\/dyp308","volume":"39","author":"K Lonnroth","year":"2010","unstructured":"Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149\u201355. https:\/\/doi.org\/10.1093\/ije\/dyp308.","journal-title":"Int J Epidemiol"},{"key":"7368_CR41","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","volume":"24","author":"CF Hanrahan","year":"2010","unstructured":"Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, et al. Body mass index and risk of tuberculosis and death. AIDS. 2010;24:1501\u20138. https:\/\/doi.org\/10.1097\/QAD.0b013e32833a2a4a.","journal-title":"AIDS"},{"key":"7368_CR42","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJL Murray","year":"2020","unstructured":"Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396:1223\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2.","journal-title":"The Lancet"},{"key":"7368_CR43","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/QAD.0000000000001902","volume":"32","author":"AE Shapiro","year":"2018","unstructured":"Shapiro AE, Hong T, Govere S, Thulare H, Moosa M-Y, Dorasamy A, et al. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. AIDS. 2018;32:1811\u201320. https:\/\/doi.org\/10.1097\/QAD.0000000000001902.","journal-title":"AIDS"},{"key":"7368_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S1473-3099(17)30488-7","volume":"17","author":"C Yoon","year":"2017","unstructured":"Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L, et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2017;17:1285\u201392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30488-7.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07368-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T16:03:55Z","timestamp":1650470635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7368"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07368-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"4 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Yunnan AIDS Care Center Ethics Review board (No. 201601). All participants gave written informed consent to participate in this study. The consent form was approved as part of the ethics approval process. All methods were performed in accordance with the relevant guidelines and regulations required by the Yunnan AIDS Care Center Ethics Review board. The study was not included personal identification and all data in analyses were anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}